NCT03678883 2026-04-039-ING-41 in Patients With Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT04521686 2025-06-27Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsEli Lilly and CompanyPhase 1 Active not recruiting200 enrolled
NCT03434262 2024-05-31SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain TumorsSt. Jude Children's Research HospitalPhase 1 Completed68 enrolled
NCT04051047 2019-11-27Gemcitabine in Newly-Diagnosed Diffuse Midline GliomaUniversity of Michigan Rogel Cancer CenterPhase EARLY_PHASE1 Withdrawn